Mercedes Rincon
Concepts (364)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Interleukin-6 | 17 | 2025 | 778 | 3.450 |
Why?
| | Mitochondria | 10 | 2025 | 946 | 2.680 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 10 | 2018 | 283 | 2.260 |
Why?
| | Glycogen Synthase Kinase 3 beta | 6 | 2025 | 72 | 1.930 |
Why?
| | STAT3 Transcription Factor | 5 | 2025 | 206 | 1.760 |
Why?
| | Mitochondrial Proteins | 6 | 2024 | 256 | 1.670 |
Why?
| | CD8-Positive T-Lymphocytes | 7 | 2025 | 913 | 1.550 |
Why?
| | CD4-Positive T-Lymphocytes | 12 | 2025 | 1095 | 1.480 |
Why?
| | Molecular Chaperones | 3 | 2020 | 195 | 1.390 |
Why?
| | HSP40 Heat-Shock Proteins | 4 | 2023 | 27 | 1.310 |
Why?
| | Interleukins | 5 | 2016 | 251 | 1.110 |
Why?
| | Thymocytes | 2 | 2025 | 35 | 0.940 |
Why?
| | Receptors, Interleukin-6 | 4 | 2013 | 43 | 0.870 |
Why?
| | Orthomyxoviridae Infections | 4 | 2025 | 76 | 0.840 |
Why?
| | Mice | 43 | 2025 | 17759 | 0.810 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2025 | 337 | 0.810 |
Why?
| | Adenosine Triphosphate | 3 | 2021 | 487 | 0.790 |
Why?
| | Animals | 52 | 2025 | 36850 | 0.760 |
Why?
| | Lymphocyte Activation | 9 | 2025 | 1150 | 0.740 |
Why?
| | Phosphoserine | 2 | 2020 | 34 | 0.730 |
Why?
| | Immunotherapy, Adoptive | 1 | 2024 | 321 | 0.680 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2021 | 137 | 0.670 |
Why?
| | MAP Kinase Signaling System | 5 | 2014 | 320 | 0.660 |
Why?
| | Mice, Inbred C57BL | 21 | 2025 | 5750 | 0.640 |
Why?
| | Cell Respiration | 4 | 2024 | 102 | 0.620 |
Why?
| | Electron Transport Complex I | 2 | 2023 | 41 | 0.610 |
Why?
| | Orthomyxoviridae | 2 | 2016 | 43 | 0.570 |
Why?
| | Allergens | 3 | 2020 | 408 | 0.560 |
Why?
| | Fatty Acids | 1 | 2020 | 442 | 0.540 |
Why?
| | Cell Movement | 1 | 2021 | 968 | 0.530 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2020 | 279 | 0.530 |
Why?
| | Aspergillus fumigatus | 4 | 2011 | 26 | 0.520 |
Why?
| | Cell Differentiation | 7 | 2021 | 1982 | 0.520 |
Why?
| | Eosinophils | 3 | 2020 | 332 | 0.520 |
Why?
| | Asthma | 5 | 2020 | 2282 | 0.520 |
Why?
| | Biopsy, Large-Core Needle | 1 | 2016 | 14 | 0.510 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2016 | 20 | 0.510 |
Why?
| | Lymphocytes | 2 | 2018 | 393 | 0.510 |
Why?
| | B-Lymphocytes | 4 | 2016 | 846 | 0.510 |
Why?
| | Inflammation | 10 | 2020 | 2835 | 0.500 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2021 | 800 | 0.490 |
Why?
| | Cell Death | 1 | 2017 | 372 | 0.490 |
Why?
| | Phosphorylation | 9 | 2025 | 1758 | 0.490 |
Why?
| | Lung | 12 | 2025 | 4063 | 0.480 |
Why?
| | Mice, Knockout | 14 | 2025 | 3009 | 0.480 |
Why?
| | Gene Expression Regulation | 8 | 2018 | 2605 | 0.470 |
Why?
| | Cytokines | 6 | 2021 | 2084 | 0.450 |
Why?
| | Respiratory Hypersensitivity | 3 | 2020 | 69 | 0.450 |
Why?
| | Breast Neoplasms | 4 | 2025 | 2234 | 0.450 |
Why?
| | Immunoglobulin G | 3 | 2016 | 887 | 0.450 |
Why?
| | Fear | 1 | 2017 | 338 | 0.440 |
Why?
| | Behavior, Animal | 1 | 2017 | 497 | 0.430 |
Why?
| | Cerebral Cortex | 1 | 2017 | 433 | 0.430 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2013 | 33 | 0.410 |
Why?
| | NFATC Transcription Factors | 4 | 2009 | 95 | 0.410 |
Why?
| | Antigens, Fungal | 3 | 2009 | 28 | 0.410 |
Why?
| | Immunologic Memory | 3 | 2016 | 370 | 0.390 |
Why?
| | Erythroid Cells | 1 | 2012 | 10 | 0.390 |
Why?
| | Disease Models, Animal | 5 | 2020 | 4282 | 0.380 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 5 | 2014 | 68 | 0.370 |
Why?
| | Liver | 1 | 2020 | 1940 | 0.360 |
Why?
| | beta-Glucans | 1 | 2011 | 20 | 0.360 |
Why?
| | Spleen | 2 | 2012 | 514 | 0.350 |
Why?
| | Lipid Metabolism | 1 | 2013 | 512 | 0.320 |
Why?
| | Biopsy | 1 | 2013 | 1124 | 0.320 |
Why?
| | Neurons | 2 | 2020 | 1587 | 0.310 |
Why?
| | Epithelial Cells | 3 | 2022 | 1094 | 0.310 |
Why?
| | Wounds and Injuries | 1 | 2016 | 755 | 0.310 |
Why?
| | T-Lymphocytes | 3 | 2019 | 1993 | 0.310 |
Why?
| | Cell Cycle | 2 | 2009 | 601 | 0.300 |
Why?
| | Mucins | 1 | 2009 | 73 | 0.300 |
Why?
| | Th2 Cells | 5 | 2012 | 176 | 0.300 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2009 | 43 | 0.300 |
Why?
| | Multiple Sclerosis | 2 | 2013 | 455 | 0.290 |
Why?
| | Respiratory Mucosa | 1 | 2011 | 322 | 0.290 |
Why?
| | Cell Nucleus | 3 | 2020 | 617 | 0.290 |
Why?
| | Neoplasm Metastasis | 4 | 2025 | 657 | 0.290 |
Why?
| | ADAM Proteins | 1 | 2008 | 61 | 0.290 |
Why?
| | Lung Diseases | 2 | 2012 | 768 | 0.290 |
Why?
| | Respiratory System | 1 | 2009 | 157 | 0.280 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2008 | 82 | 0.280 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2008 | 80 | 0.280 |
Why?
| | Cell Line, Tumor | 4 | 2024 | 3406 | 0.270 |
Why?
| | RNA, Small Interfering | 2 | 2020 | 622 | 0.270 |
Why?
| | Antibody Formation | 1 | 2009 | 298 | 0.270 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2013 | 801 | 0.270 |
Why?
| | Signal Transduction | 8 | 2025 | 5077 | 0.270 |
Why?
| | Cells, Cultured | 8 | 2020 | 4192 | 0.250 |
Why?
| | Mice, SCID | 2 | 2021 | 366 | 0.240 |
Why?
| | Female | 18 | 2025 | 72816 | 0.240 |
Why?
| | Interleukin-2 | 1 | 2007 | 455 | 0.240 |
Why?
| | Th17 Cells | 2 | 2020 | 109 | 0.240 |
Why?
| | Ovalbumin | 2 | 2024 | 183 | 0.240 |
Why?
| | V(D)J Recombination | 1 | 2025 | 8 | 0.230 |
Why?
| | Membrane Proteins | 2 | 2010 | 1163 | 0.230 |
Why?
| | Humans | 27 | 2025 | 136803 | 0.230 |
Why?
| | Paclitaxel | 1 | 2006 | 227 | 0.230 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2006 | 190 | 0.230 |
Why?
| | Mice, Transgenic | 10 | 2014 | 2163 | 0.220 |
Why?
| | Pneumonia | 1 | 2010 | 635 | 0.220 |
Why?
| | Arthritis, Rheumatoid | 1 | 2013 | 1167 | 0.210 |
Why?
| | Electron Transport Complex II | 1 | 2023 | 26 | 0.210 |
Why?
| | Melanoma, Experimental | 1 | 2024 | 114 | 0.210 |
Why?
| | Models, Immunological | 2 | 2013 | 100 | 0.200 |
Why?
| | Calcium | 2 | 2021 | 1197 | 0.200 |
Why?
| | Acetaminophen | 1 | 2025 | 266 | 0.190 |
Why?
| | In Vitro Techniques | 2 | 2021 | 1089 | 0.190 |
Why?
| | Interferon-gamma | 4 | 2016 | 789 | 0.190 |
Why?
| | Protein Kinase Inhibitors | 1 | 2008 | 916 | 0.190 |
Why?
| | Natural Killer T-Cells | 2 | 2013 | 67 | 0.190 |
Why?
| | Th1 Cells | 4 | 2012 | 143 | 0.180 |
Why?
| | Drug Resistance, Multiple | 1 | 2021 | 25 | 0.180 |
Why?
| | Neoplasms | 3 | 2023 | 2643 | 0.170 |
Why?
| | Receptors, Interleukin-21 | 2 | 2012 | 2 | 0.170 |
Why?
| | Antigens, Neoplasm | 1 | 2023 | 319 | 0.170 |
Why?
| | Biomimetic Materials | 1 | 2021 | 72 | 0.170 |
Why?
| | Neutrophils | 2 | 2020 | 1236 | 0.160 |
Why?
| | Datasets as Topic | 1 | 2020 | 119 | 0.160 |
Why?
| | Sonication | 1 | 2019 | 13 | 0.160 |
Why?
| | Primary Cell Culture | 1 | 2020 | 171 | 0.160 |
Why?
| | Receptors, Antigen, T-Cell | 3 | 2009 | 718 | 0.160 |
Why?
| | Pulmonary Fibrosis | 2 | 2022 | 399 | 0.160 |
Why?
| | Mice, Inbred NOD | 1 | 2021 | 600 | 0.160 |
Why?
| | Doxorubicin | 1 | 2021 | 362 | 0.160 |
Why?
| | Hepatocytes | 1 | 2020 | 220 | 0.150 |
Why?
| | Diet, High-Fat | 1 | 2020 | 247 | 0.150 |
Why?
| | Receptors, Histamine H1 | 2 | 2008 | 5 | 0.150 |
Why?
| | Lymphocyte Subsets | 2 | 2016 | 87 | 0.140 |
Why?
| | Male | 13 | 2021 | 67330 | 0.140 |
Why?
| | Oxygen Consumption | 1 | 2021 | 695 | 0.140 |
Why?
| | Septal Nuclei | 1 | 2018 | 23 | 0.140 |
Why?
| | Lung Neoplasms | 2 | 2025 | 2489 | 0.140 |
Why?
| | Cell Survival | 3 | 2010 | 1116 | 0.130 |
Why?
| | Leukocyte Common Antigens | 3 | 2013 | 87 | 0.130 |
Why?
| | Histones | 2 | 2023 | 636 | 0.130 |
Why?
| | Cell Proliferation | 4 | 2025 | 2476 | 0.130 |
Why?
| | Immunoglobulin Class Switching | 1 | 2016 | 20 | 0.130 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 556 | 0.130 |
Why?
| | Autoimmunity | 2 | 2014 | 908 | 0.130 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1059 | 0.130 |
Why?
| | Animals, Newborn | 3 | 2020 | 844 | 0.130 |
Why?
| | Autoimmune Diseases | 2 | 2012 | 460 | 0.130 |
Why?
| | Transcriptional Activation | 2 | 2009 | 378 | 0.120 |
Why?
| | Hypersensitivity | 2 | 2009 | 257 | 0.120 |
Why?
| | Oxidative Phosphorylation | 1 | 2016 | 193 | 0.120 |
Why?
| | Threonine-tRNA Ligase | 1 | 2014 | 5 | 0.110 |
Why?
| | Tumor Microenvironment | 2 | 2016 | 672 | 0.110 |
Why?
| | Nanoparticles | 1 | 2020 | 478 | 0.110 |
Why?
| | Tumor Cells, Cultured | 1 | 2016 | 953 | 0.110 |
Why?
| | Adipose Tissue, White | 1 | 2014 | 41 | 0.110 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2014 | 49 | 0.110 |
Why?
| | Mitogen-Activated Protein Kinase 14 | 1 | 2014 | 7 | 0.110 |
Why?
| | Adipose Tissue, Brown | 1 | 2014 | 53 | 0.110 |
Why?
| | Antigens, CD1d | 1 | 2013 | 68 | 0.110 |
Why?
| | Brain | 2 | 2020 | 2664 | 0.110 |
Why?
| | Cachexia | 1 | 2014 | 71 | 0.100 |
Why?
| | Rotenone | 1 | 2013 | 11 | 0.100 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2013 | 71 | 0.100 |
Why?
| | Ki-67 Antigen | 1 | 2013 | 111 | 0.100 |
Why?
| | Intracellular Membranes | 1 | 2013 | 84 | 0.100 |
Why?
| | Reactive Oxygen Species | 1 | 2016 | 621 | 0.100 |
Why?
| | Clinical Trials, Phase III as Topic | 1 | 2013 | 105 | 0.100 |
Why?
| | Anti-Inflammatory Agents | 2 | 2014 | 496 | 0.100 |
Why?
| | Polymorphism, Genetic | 2 | 2013 | 659 | 0.100 |
Why?
| | Metabolome | 1 | 2016 | 350 | 0.100 |
Why?
| | Myeloid Cells | 1 | 2014 | 148 | 0.100 |
Why?
| | Coxsackievirus Infections | 1 | 2012 | 14 | 0.100 |
Why?
| | Enterovirus B, Human | 1 | 2012 | 26 | 0.100 |
Why?
| | Hippocampus | 1 | 2017 | 894 | 0.090 |
Why?
| | Tumor Burden | 1 | 2013 | 309 | 0.090 |
Why?
| | Mucus | 2 | 2009 | 79 | 0.090 |
Why?
| | Orchitis | 2 | 2008 | 5 | 0.090 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2011 | 27 | 0.090 |
Why?
| | Aged | 3 | 2020 | 23808 | 0.090 |
Why?
| | Protein Modification, Translational | 1 | 2011 | 2 | 0.090 |
Why?
| | Serine | 2 | 2010 | 141 | 0.090 |
Why?
| | Cholesterol | 1 | 2013 | 410 | 0.090 |
Why?
| | Myocarditis | 1 | 2012 | 100 | 0.090 |
Why?
| | Interleukin-17 | 1 | 2011 | 119 | 0.090 |
Why?
| | Promoter Regions, Genetic | 2 | 2013 | 1249 | 0.090 |
Why?
| | Fatty Liver | 1 | 2013 | 243 | 0.080 |
Why?
| | Adult | 4 | 2020 | 37643 | 0.080 |
Why?
| | Inflammation Mediators | 1 | 2013 | 513 | 0.080 |
Why?
| | Middle Aged | 4 | 2020 | 33239 | 0.080 |
Why?
| | Macrophages | 2 | 2016 | 1544 | 0.080 |
Why?
| | Antineoplastic Agents | 1 | 2021 | 2123 | 0.080 |
Why?
| | X-Rays | 1 | 2009 | 28 | 0.080 |
Why?
| | Repressor Proteins | 1 | 2013 | 427 | 0.080 |
Why?
| | Stress, Psychological | 1 | 2018 | 1097 | 0.080 |
Why?
| | Cell Extracts | 1 | 2009 | 21 | 0.080 |
Why?
| | Interleukin-6 Receptor alpha Subunit | 1 | 2009 | 1 | 0.080 |
Why?
| | Metaplasia | 1 | 2009 | 60 | 0.080 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2010 | 188 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 233 | 0.070 |
Why?
| | Biomarkers | 2 | 2012 | 4145 | 0.070 |
Why?
| | Sex Characteristics | 1 | 2014 | 763 | 0.070 |
Why?
| | ADAM17 Protein | 1 | 2008 | 35 | 0.070 |
Why?
| | Catalytic Domain | 1 | 2009 | 207 | 0.070 |
Why?
| | Disease Progression | 1 | 2016 | 2751 | 0.070 |
Why?
| | ADAM10 Protein | 1 | 2008 | 30 | 0.070 |
Why?
| | Ovarian Neoplasms | 1 | 2014 | 562 | 0.070 |
Why?
| | Antigen Presentation | 2 | 2023 | 216 | 0.070 |
Why?
| | Ventricular Myosins | 1 | 2008 | 35 | 0.070 |
Why?
| | Mice, Inbred Strains | 1 | 2009 | 409 | 0.070 |
Why?
| | Recombination, Genetic | 1 | 2009 | 200 | 0.070 |
Why?
| | Immunoglobulin M | 1 | 2009 | 289 | 0.070 |
Why?
| | DNA Repair | 1 | 2009 | 231 | 0.070 |
Why?
| | Biomarkers, Tumor | 1 | 2014 | 1272 | 0.070 |
Why?
| | Receptors, Steroid | 1 | 2007 | 50 | 0.070 |
Why?
| | Aging | 2 | 2020 | 1864 | 0.070 |
Why?
| | Asbestos, Serpentine | 1 | 2007 | 6 | 0.070 |
Why?
| | Thymus Gland | 1 | 2008 | 313 | 0.070 |
Why?
| | Myosin Heavy Chains | 1 | 2008 | 191 | 0.070 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2008 | 142 | 0.070 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2010 | 429 | 0.070 |
Why?
| | Flow Cytometry | 3 | 2019 | 1180 | 0.060 |
Why?
| | Protein Kinase C-delta | 1 | 2007 | 48 | 0.060 |
Why?
| | Tamoxifen | 1 | 2007 | 202 | 0.060 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 851 | 0.060 |
Why?
| | Immunity, Innate | 1 | 2012 | 825 | 0.060 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2007 | 161 | 0.060 |
Why?
| | Proto-Oncogene Proteins | 1 | 2010 | 647 | 0.060 |
Why?
| | beta Catenin | 1 | 2008 | 253 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2008 | 437 | 0.060 |
Why?
| | Cytochrome P-450 CYP2E1 | 1 | 2025 | 31 | 0.060 |
Why?
| | Leukocytes, Mononuclear | 1 | 2008 | 558 | 0.060 |
Why?
| | Enzyme Activation | 3 | 2014 | 810 | 0.060 |
Why?
| | Autoantibodies | 1 | 2013 | 1496 | 0.060 |
Why?
| | Diet | 1 | 2013 | 1274 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 185 | 0.060 |
Why?
| | Epitopes | 1 | 2007 | 480 | 0.060 |
Why?
| | Interleukin-13 | 1 | 2005 | 149 | 0.060 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2025 | 93 | 0.060 |
Why?
| | Antibodies, Viral | 1 | 2009 | 624 | 0.060 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2012 | 1036 | 0.060 |
Why?
| | Models, Biological | 2 | 2008 | 1773 | 0.050 |
Why?
| | Aged, 80 and over | 1 | 2016 | 7593 | 0.050 |
Why?
| | Bone Marrow Cells | 1 | 2005 | 316 | 0.050 |
Why?
| | Kaplan-Meier Estimate | 1 | 2006 | 888 | 0.050 |
Why?
| | Lipopolysaccharides | 2 | 2022 | 886 | 0.050 |
Why?
| | Gene Expression | 1 | 2009 | 1500 | 0.050 |
Why?
| | Electrons | 1 | 2023 | 83 | 0.050 |
Why?
| | Gene Knockout Techniques | 1 | 2023 | 117 | 0.050 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2006 | 326 | 0.050 |
Why?
| | Methylation | 1 | 2023 | 230 | 0.050 |
Why?
| | Membrane Glycoproteins | 1 | 2005 | 500 | 0.050 |
Why?
| | Heart Atria | 1 | 2003 | 137 | 0.050 |
Why?
| | Bacteria | 1 | 2009 | 854 | 0.050 |
Why?
| | Time Factors | 2 | 2018 | 6809 | 0.050 |
Why?
| | Epithelium | 1 | 2022 | 311 | 0.040 |
Why?
| | NF-kappa B | 1 | 2005 | 691 | 0.040 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2007 | 1058 | 0.040 |
Why?
| | Apoptosis | 1 | 2010 | 2552 | 0.040 |
Why?
| | RNA, Messenger | 1 | 2007 | 2831 | 0.040 |
Why?
| | Neural Stem Cells | 1 | 2020 | 155 | 0.040 |
Why?
| | Astrocytes | 1 | 2020 | 210 | 0.040 |
Why?
| | Nuclear Proteins | 1 | 2003 | 712 | 0.040 |
Why?
| | Mice, Inbred BALB C | 2 | 2011 | 1269 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2003 | 858 | 0.040 |
Why?
| | Microglia | 1 | 2020 | 251 | 0.040 |
Why?
| | Myocardium | 1 | 2003 | 1001 | 0.040 |
Why?
| | DNA Damage | 1 | 2020 | 420 | 0.040 |
Why?
| | Models, Animal | 1 | 2019 | 384 | 0.030 |
Why?
| | Reflex, Startle | 1 | 2018 | 65 | 0.030 |
Why?
| | Prognosis | 1 | 2006 | 4013 | 0.030 |
Why?
| | Blotting, Western | 1 | 2019 | 1225 | 0.030 |
Why?
| | Melanoma | 1 | 2023 | 757 | 0.030 |
Why?
| | Active Transport, Cell Nucleus | 2 | 2009 | 123 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2003 | 1501 | 0.030 |
Why?
| | Transcription Factors | 1 | 2003 | 1718 | 0.030 |
Why?
| | Uncoupling Protein 1 | 1 | 2014 | 16 | 0.030 |
Why?
| | Homeostasis | 2 | 2010 | 619 | 0.030 |
Why?
| | Weight Gain | 1 | 2018 | 519 | 0.030 |
Why?
| | Ion Channels | 1 | 2014 | 133 | 0.030 |
Why?
| | Neovascularization, Pathologic | 1 | 2014 | 301 | 0.020 |
Why?
| | Cell Line | 2 | 2008 | 2838 | 0.020 |
Why?
| | Mutation | 3 | 2010 | 3947 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2014 | 543 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2006 | 10748 | 0.020 |
Why?
| | Adoptive Transfer | 1 | 2012 | 224 | 0.020 |
Why?
| | MAP Kinase Kinase 3 | 1 | 2011 | 7 | 0.020 |
Why?
| | MAP Kinase Kinase 6 | 1 | 2011 | 3 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 1321 | 0.020 |
Why?
| | Anxiety | 1 | 2018 | 1031 | 0.020 |
Why?
| | Cell Separation | 1 | 2011 | 317 | 0.020 |
Why?
| | Hydrocolpos | 1 | 2010 | 5 | 0.020 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2011 | 187 | 0.020 |
Why?
| | Bcl-2-Like Protein 11 | 1 | 2010 | 38 | 0.020 |
Why?
| | Limb Deformities, Congenital | 1 | 2010 | 14 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2010 | 162 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2010 | 298 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1242 | 0.020 |
Why?
| | Candida albicans | 1 | 2009 | 54 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2012 | 363 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2009 | 225 | 0.020 |
Why?
| | Ca(2+) Mg(2+)-ATPase | 1 | 2008 | 3 | 0.020 |
Why?
| | Propylthiouracil | 1 | 2008 | 5 | 0.020 |
Why?
| | Muscle, Smooth | 1 | 2009 | 155 | 0.020 |
Why?
| | GTP-Binding Protein alpha Subunits | 1 | 2008 | 16 | 0.020 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2009 | 99 | 0.020 |
Why?
| | Organ Size | 1 | 2009 | 477 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2014 | 919 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 1059 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 125 | 0.020 |
Why?
| | Liver Diseases | 1 | 2011 | 311 | 0.020 |
Why?
| | Vagina | 1 | 2010 | 186 | 0.020 |
Why?
| | Histamine | 1 | 2007 | 67 | 0.020 |
Why?
| | Antigens | 1 | 2009 | 358 | 0.020 |
Why?
| | Cyclin D1 | 1 | 2007 | 68 | 0.020 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 2007 | 59 | 0.020 |
Why?
| | Immunologic Factors | 1 | 2009 | 236 | 0.020 |
Why?
| | Toll-Like Receptor 4 | 1 | 2009 | 273 | 0.020 |
Why?
| | Arginine | 1 | 2008 | 271 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2008 | 403 | 0.020 |
Why?
| | Protein Transport | 1 | 2008 | 443 | 0.020 |
Why?
| | Haplotypes | 1 | 2008 | 494 | 0.020 |
Why?
| | Pseudomonas aeruginosa | 1 | 2009 | 352 | 0.020 |
Why?
| | STAT6 Transcription Factor | 1 | 2005 | 27 | 0.020 |
Why?
| | Nippostrongylus | 1 | 2005 | 4 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 2184 | 0.020 |
Why?
| | Strongylida Infections | 1 | 2005 | 7 | 0.020 |
Why?
| | Immunity | 1 | 2006 | 144 | 0.020 |
Why?
| | Endoplasmic Reticulum | 1 | 2008 | 264 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2007 | 283 | 0.020 |
Why?
| | Pre-B Cell Receptors | 1 | 2005 | 1 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-rel | 1 | 2005 | 9 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 152 | 0.010 |
Why?
| | Receptors, Progesterone | 1 | 2007 | 349 | 0.010 |
Why?
| | Matrix Metalloproteinases | 1 | 2005 | 95 | 0.010 |
Why?
| | Chronic Disease | 1 | 2011 | 1786 | 0.010 |
Why?
| | Alleles | 1 | 2008 | 890 | 0.010 |
Why?
| | Luciferases | 1 | 2005 | 149 | 0.010 |
Why?
| | Retroviridae | 1 | 2005 | 97 | 0.010 |
Why?
| | Receptor, ErbB-2 | 1 | 2007 | 340 | 0.010 |
Why?
| | Organ Specificity | 1 | 2005 | 304 | 0.010 |
Why?
| | Chemokines | 1 | 2005 | 228 | 0.010 |
Why?
| | Influenza A virus | 1 | 2005 | 110 | 0.010 |
Why?
| | Cell Membrane | 1 | 2008 | 735 | 0.010 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2005 | 130 | 0.010 |
Why?
| | Genes, Reporter | 1 | 2005 | 268 | 0.010 |
Why?
| | Receptors, Estrogen | 1 | 2007 | 436 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2011 | 1430 | 0.010 |
Why?
| | Gene Transfer Techniques | 1 | 2005 | 169 | 0.010 |
Why?
| | Green Fluorescent Proteins | 1 | 2005 | 390 | 0.010 |
Why?
| | Multivariate Analysis | 1 | 2007 | 1507 | 0.010 |
Why?
| | Genes, Regulator | 1 | 2003 | 37 | 0.010 |
Why?
| | Killer Cells, Natural | 1 | 2007 | 443 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 2007 | 1373 | 0.010 |
Why?
| | Antibodies | 1 | 2005 | 411 | 0.010 |
Why?
| | Troponin T | 1 | 2003 | 67 | 0.010 |
Why?
| | Sarcomeres | 1 | 2003 | 95 | 0.010 |
Why?
| | Models, Molecular | 1 | 2008 | 1570 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 2003 | 432 | 0.010 |
Why?
| | Lymph Nodes | 1 | 2005 | 492 | 0.010 |
Why?
| | Troponin I | 1 | 2003 | 81 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2007 | 2022 | 0.010 |
Why?
| | Down-Regulation | 1 | 2003 | 656 | 0.010 |
Why?
| | Binding Sites | 1 | 2003 | 1301 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2008 | 2412 | 0.010 |
Why?
| | Protein Binding | 1 | 2005 | 2216 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2005 | 1455 | 0.010 |
Why?
| | Myocytes, Cardiac | 1 | 2003 | 523 | 0.010 |
Why?
| | DNA | 1 | 2005 | 1458 | 0.010 |
Why?
| | Fetus | 1 | 2003 | 806 | 0.010 |
Why?
|
|
Rincon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|